Thasso
the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
Log in
Main Navigation
‹ Return to Eribulin Mesylate (Halaven): First drug to show survival benefit in unresectable or metastatic liposarcoma
Eribulin Mesylate (Halaven)
You must be logged in to post a comment.
Optional: Social Subscribe/Login
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Leave a Reply
You must be logged in to post a comment.
Optional: Social Subscribe/Login